Adjuvant effect of HER-2/neu-specific adenoviral vector stimulating CD8+ T and natural killer cell responses on anti-HER-2/neu antibody therapy for well-established breast tumors in HER-2/neu transgenic mice
Y Chen, J Xiang(University of Saskatchewan), Qinying Liu(University of Saskatchewan), Shahid Ahmed(Emory University), Amer Sami(University of Saskatchewan), Tim Hon Man Chan(Sun Yat-sen University), Yufeng Xie(Fudan University)
Cited by 13
Related Papers
Obesity and Cancer: A Current Overview of Epidemiology, Pathogenesis, Outcomes, and Management
|Cancers|2023|640
Gallbladder Cancer in the 21st Century
|Journal of Oncology|2015|301
HER2-directed therapy: current treatment options for HER2-positive breast cancer
|Breast Cancer|2015|183
Diabetes and Cancer: Risk, Challenges, Management and Outcomes
|Cancers|2021|183
Current status of immunotherapy in metastatic colorectal cancer
|International Journal of Colorectal Disease|2018|149